Margaret O. Johnson

Neuro-Oncologist
Duke University Medical Center

Margaret O. Johnson, MD, MPH

Dr. Johnson completed her residency in Adult Neurology and fellowship in Hospice and Palliative Medicine at the Hospital of the University of Pennsylvania. She completed a one-year fellowship in Neuro-oncology at The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center. Upon completion of her fellowship in October 2017, she joined the Center as faculty. Dr. Johnson’s primary focuses are patient care and clinical research. Her clinical research focuses on using patient-centered outcomes to evaluate systems-based models of delivering integrated palliative care to brain tumor patients. In addition, she has a particular interest in better understanding and improving health outcomes in elderly oncology patients.

Disclosure: NO DISCLOSURE DATA

Presentation(s):

• QOLP-18 - A time-based model of early palliative care intervention in patients with newly diagnosed glioblastoma, a single institution feasibility study

  Friday, November 22
  7:30 PM – 9:30 PM

• ATIM-24 - Dose finding and dose expansion trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG)

  Friday, November 22
  7:30 PM – 9:30 PM

• QOLP-29 - Mindfulness meditation practice in malignant glioma patients throughout concomitant radiation and temozolomide: A feasibility study

  Saturday, November 23
  5:00 PM – 7:00 PM

• HOUT-21 - Characteristics of Short-Term Survival in Patients with Glioblastoma: A Retrospective Analysis

  Saturday, November 23
  5:00 PM – 7:00 PM

• ATIM-31 - Safety of Tumor-Specific Peptide Vaccine Targeting Isocitrate Dehydrogenase 1 Mutation in Recurrent Resectable Low Grade Glioma Patients

  Sunday, November 24
  9:50 AM – 9:55 AM